Biopharma Insights

IgGenix Advances Therapeutic Approach to Peanut Allergies with IgG4 Monoclonal Antibodies

IgGenix, Inc., a California-based preclinical antibody discovery and development company, recently reported advances towards a potential therapeutic solution for peanut …

Continue ›››

Collaborative Open-Source Approaches Are the New Norm in Life Sciences Research, According to Survey

Life sciences research has experienced significant shifts in its operational paradigms in recent years, driven largely by the advent and …

Continue ›››

The Rising Role of AI-enabled Digital Pathology in Drug Discovery

The field of pathology has experienced a major shift over the past few decades. This evolution began as early as …

Continue ›››

Harnessing AI for Drug Discovery Certara Amplifies CODEX Platform Capabilities

Certara, a leader in biosimulation, has recently expanded the horizons of AI in drug discovery with the introduction of artificial …

Continue ›››

Collaboration Between Iktos and Curreio Harnesses AI and Cryo-EM for Drug Discovery

Iktos, a French AI-focused company specializing in new drug design, and Curreio, a Japanese cryo-electron microscopy (cryo-EM) expert, have recently …

Continue ›››

CEPI and aVaxziPen Partner to Advance Needle-Free Vaccine Delivery Aiming for Equitable Global Access

Needle-free vaccine delivery has emerged as a promising solution to overcome the challenges associated with frozen storage requirements, thereby improving …

Continue ›››

BenevolentAI Pioneers AI-Driven Drug Discovery for ALS Treatment

Incorporating AI in drug discovery is rapidly becoming a common practice in the pharmaceutical industry. The recent undertakings of UK-based …

Continue ›››

Owkin Advances AI in Drug Discovery with Launching $50 Million MOSAIC Project

Owkin, an AI biotech firm, is partnering with NanoString Technologies and other notable cancer research institutions to spearhead the MOSAIC …

Continue ›››

ReproCell, IBM, and HNCDI Debut Pharmacology-AI to Boost Efficiency of Drug Discovery

ReproCell, a well-established life sciences company, recently revealed its latest service offering, Pharmacology-AI. This service is the result of a …

Continue ›››

Seqera Labs Joins Forces with Genomics England to Boost Genomic Medicine Research

Seqera Labs, recognized for its secure workflow orchestration software in the life sciences domain, is aligning forces with Genomics England, …

Continue ›››

FDA IND Approval of AI-derived Cancer Drug ISM3091 Marks a Milestone for Insilico Medicine

In an essential leap forward for the utilization of artificial intelligence (AI) in drug discovery, Insilico Medicine secured Investigational New …

Continue ›››

Eli Lilly Collaborates with XtalPi to Harness AI in Drug Discovery

XtalPi Inc., a company that uses artificial intelligence (AI) and automation in pharmaceutical technology, is set to collaborate with Eli …

Continue ›››